Studies in the Modulation of Experimental Autoimmune Encephalomyelitis

被引:0
|
作者
Jane E. Libbey
Ikuo Tsunoda
Robert S. Fujinami
机构
[1] University of Utah School of Medicine,Department of Pathology
[2] Louisiana State University Health Sciences Center,Department of Microbiology and Immunology
来源
关键词
myelin basic protein; myelin proteolipid protein; myelin oligodendrocyte glycoprotein; vaccination; DNA immunization; interleukin-17;
D O I
暂无
中图分类号
学科分类号
摘要
Experimental autoimmune encephalomyelitis (EAE), an experimental model for multiple sclerosis, can be induced through inoculation with several different central nervous system (CNS) proteins or peptides. Modulation of EAE, resulting in either protection from EAE or enhancement of EAE, can also be accomplished through either vaccination or DNA immunization with molecular mimics of self-CNS proteins. Previously published data on this method of EAE modulation will be reviewed. New data is presented, which demonstrates that EAE can also be modulated through the administration of the β-(1,3)-d-glucan, curdlan. Dendritic cells stimulated by curdlan are involved in the differentiation of the interleukin-17 producing subset of CD4+ T cells that are recognized effector cells in EAE. Using two different systems to study the effects of curdlan on EAE, it was found that curdlan increased the incidence of EAE and/or the severity of the disease course.
引用
收藏
页码:168 / 175
页数:7
相关论文
共 50 条
  • [41] Neuroprotection by Ulinastatin in Experimental Autoimmune Encephalomyelitis
    Shu, Yaqing
    Yang, Yu
    Qiu, Wei
    Lu, Zhengqi
    Li, Ying
    Bao, Jian
    Feng, Ming
    Hu, Xueqiang
    [J]. NEUROCHEMICAL RESEARCH, 2011, 36 (11) : 1969 - 1977
  • [42] Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
    Paris, Daniel
    Beaulieu-Abdelahad, David
    Mullan, Myles
    Ait-Ghezala, Ghania
    Mathura, Venkat
    Bachmeier, Corbin
    Crawford, Fiona
    Mullan, Michael J.
    [J]. PLOS ONE, 2013, 8 (01):
  • [43] Acamprosate modulates experimental autoimmune encephalomyelitis
    Sternberg Z.
    Cesario A.
    Rittenhouse-Olson K.
    Sobel R.A.
    Pankewycz O.
    Zhu B.
    Whitcomb T.
    Sternberg D.S.
    Munschauer F.E.
    [J]. Inflammopharmacology, 2012, 20 (1) : 39 - 48
  • [44] The origin and application of experimental autoimmune encephalomyelitis
    Baxter, Alan G.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2007, 7 (11) : 904 - 912
  • [45] REINDUCTION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN MICE
    LINDSEY, JW
    PAPPOLLA, M
    STEINMAN, L
    [J]. CELLULAR IMMUNOLOGY, 1995, 162 (02) : 235 - 240
  • [46] Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
    Shin, Taekyun
    Ahn, Meejung
    Moon, Changjong
    Kim, Seungjoon
    [J]. ANATOMY & CELL BIOLOGY, 2012, 45 (04) : 215 - 220
  • [47] Fas in murine experimental autoimmune encephalomyelitis
    Ho, PP
    Tse, HY
    [J]. FASEB JOURNAL, 1999, 13 (05): : A1002 - A1002
  • [48] Gene Therapy in Experimental Autoimmune Encephalomyelitis
    Peter M. Mathisen
    Vincent K. Tuohy
    [J]. Journal of Clinical Immunology, 2000, 20 : 327 - 333
  • [49] Peptide immunotherapy in experimental autoimmune encephalomyelitis
    Anderton, Stephen M.
    [J]. BIOMEDICAL JOURNAL, 2015, 38 (03) : 206 - 214
  • [50] SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY CANNABINOIDS
    WIRGUIN, I
    MECHOULAM, R
    BREUER, A
    SCHEZEN, E
    WEIDENFELD, J
    BRENNER, T
    [J]. IMMUNOPHARMACOLOGY, 1994, 28 (03): : 209 - 214